Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rATG in Graves Orbitopathy
NCT05199103Unknown
- Sponsor
- Medical University of Silesia
- Start
- Jan 2020
- Primary completion
- Dec 2023
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of antithymocyte globulin rabbit in Graves Orbitopathy (GO), sponsored by Medical University of Silesia. Primary endpoints: Clinical Activity Score at 48 weeks, Proptosis at 48 weeks and 3 more. Status: unknown.
02
Drugs
antithymocyte globulin rabbit
03
Conditions
Graves Orbitopathy (GO)
Beyond the preview
Go deeper on NCT05199103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05199103.